News
On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% ...
23mon MSN
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback